Sunitinib Suppress Neuroblastoma Growth through Degradation of MYCN and Inhibition of Angiogenesis
Raúl Calero +3 more
openalex +2 more sources
Oxphos targeting of <i>MYCN</i>-amplified neuroblastoma. [PDF]
Epp S +7 more
europepmc +1 more source
Clinical management and therapeutic development for the rare disease rhabdomyosarcoma. [PDF]
Ke TL, Chen L.
europepmc +1 more source
Extracellular vesicle derived miRNAs from plasma as promising diagnosis and prognosis biomarkers for neuroblastoma. [PDF]
Zhou D +9 more
europepmc +1 more source
Diagnosis and management of neuroblastoma in children. [PDF]
Braungart S, Losty PD.
europepmc +1 more source
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers. [PDF]
Montuori G +35 more
europepmc +1 more source
The dynamic systemic immuno-inflammatory index: a novel predictor of neoadjuvant chemotherapy response and outcome in high-risk pediatric neuroblastoma. [PDF]
Zhang C, Wang X, Niu H, Zhang P, Geng J.
europepmc +1 more source
MDM2 promotes CELF6 ubiquitination-dependent degradation to promote neuroblastoma cell proliferation. [PDF]
Zhao Z, Zhang B, Zhang X, Li C.
europepmc +1 more source
Emergency Surgical Management of Chemotherapy-Induced Tumor Rupture in a Patient with MYCN-Amplified Neuroblastoma: A Case Report. [PDF]
Ogawa K +14 more
europepmc +1 more source

